"7.3.2.2	  Non-seminoma  Following first-line BEP only 6-10% of residual masses contain active cancer, 50% post-pubertal teratoma,   and 40% necrotic-fibrotic tissue only [208]. Restaging patients following chemotherapy with FDG-PET is not   indicated [50-52]. With complete radiological remission, RPLND is not indicated [209, 210].",
Recommendations,Strength rating
Balance the individual patientsâ€™ potential benefits and risks of thromboprophylaxis during   first-line chemotherapy in men with metastatic germ cell tumours.,Weak
Avoid use of central venous-access devices during first-line chemotherapy whenever   possible.,Weak
